Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Richard H, Stanford"'
Autor:
Amie Scott, Jo Atkinson, Wajeeha Ansari, Maya Reimbaeva, Richard H. Stanford, Fadi Manuel, Linda Holtzman, Florin Draica
Publikováno v:
COVID, Vol 4, Iss 11, Pp 1794-1799 (2024)
A list of diagnosis codes mapped to CDC-defined high-risk conditions for severe COVID-19 outcomes is currently not available in the literature. We reviewed the CDC list of underlying conditions associated with severe COVID-19 and a coding expert and
Externí odkaz:
https://doaj.org/article/8da016cdddbb42229c0fdded660458cf
Publikováno v:
Pulmonary Therapy, Vol 5, Iss 2, Pp 191-200 (2019)
Abstract Introduction To address the burden of chronic obstructive pulmonary disease (COPD), the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends treatment according to classification of patients by symptom severity and exacer
Externí odkaz:
https://doaj.org/article/d14f80eacb7548ceabf50b96e4f0e32f
Publikováno v:
Pulmonary Therapy, Vol 5, Iss 2, Pp 179-190 (2019)
Abstract Introduction Many patients with chronic obstructive pulmonary disease (COPD) prescribed long-acting muscarinic antagonist (LAMA) monotherapy remain symptomatic. This multivariable analysis of a previously reported claims-linked, cross-sectio
Externí odkaz:
https://doaj.org/article/9ab8d070b338450482a56821de1062ef
Publikováno v:
Pulmonary Therapy, Vol 5, Iss 1, Pp 69-80 (2019)
Abstract Introduction Symptom burden in inadequately controlled chronic obstructive pulmonary disease (COPD) considerably impacts quality of life, healthcare resource utilization (HCRU) and associated costs. This claims-linked cross-sectional survey
Externí odkaz:
https://doaj.org/article/2d6c85dc9197435f9cde89e64b078f1c
Autor:
Ami R. Buikema, Lee Brekke, Amy Anderson, Eleena Koep, Damon Van Voorhis, Lucie Sharpsten, Beth Hahn, Riju Ray, Richard H. Stanford
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background Chronic obstructive pulmonary disease (COPD) is associated with high clinical and economic burden. Optimal pharmacological therapy for COPD aims to reduce symptoms and the frequency and severity of exacerbations. Umeclidinium/vila
Externí odkaz:
https://doaj.org/article/897236101786485a904ae61d6fa15229
Autor:
Vineet Bhandari, Rachel Black, Bheru Gandhi, Susan Hogue, Venkatakrishna Kakkilaya, Michel Mikhael, Fernando Moya, Chad Pezzano, Pam Read, Kari D. Roberts, Rita M. Ryan, Richard H. Stanford, Clyde J. Wright
Publikováno v:
Journal of Perinatology.
Objective To provide the best clinical practice guidance for surfactant use in preterm neonates with respiratory distress syndrome (RDS). The RDS-Neonatal Expert Taskforce (RDS-NExT) initiative was intended to add to existing evidence and clinical gu
Autor:
Tam Dang-Tan, Shiyuan Zhang, Ruben V. Tavares, Melissa Stutz, Afisi S. Ismaila, Julie Vaillancourt, Diane Corriveau, Richard H. Stanford, Xiwu Lin, Gilbert A. Nadeau, Alexander Simidchiev, Daria Parsons, John S. Sampalis
Publikováno v:
Canadian Respiratory Journal, Vol 2017 (2017)
Background. Chronic obstructive pulmonary disease (COPD) prevalence in Canada has risen over time. COPD-related exacerbations contribute to the increased health care utilization (HCU) in this population. This study investigated the impact of exacerba
Externí odkaz:
https://doaj.org/article/2884f883900d450694172db2dab9e6ac
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:198-209
BACKGROUND: Inhaled medications are the mainstay of treatment for chronic obstructive pulmonary disease (COPD). Despite their importance, adherence to these medications is low. Low adherence is linked to increased exacerbation rates, mortality rates,
Autor:
Cara Pasquale, John Linnell, Richard H. Stanford, Leanne Kaye, Ryan Tomlinson, Benjamin S Wu, Barbara P. Yawn, Elisha Malanga, Gretchen McCreary, David A. Stempel, Radmila Choate, Rahul Gondalia, Kathryn Collison, Daniel Gratie
Publikováno v:
Chronic Obstr Pulm Dis
Background:Electronic medication monitors (EMMs) are associated with decreased rescue inhaler use, symptom burden, and increased medication adherence in asthma. However, the use of EMMs in people with chronic obstructive pulmonary disease (COPD) usin
Autor:
Jamie Rees, A. Preece, Philip C. Halverson, Joel Liem, Raj Sharma, Kathryn Collison, Renu Jain, Warren Lenney, Logan Heyes, Philippe Bareille, Richard H. Stanford
Publikováno v:
Pediatric Pulmonology
Rationale Asthma studies show many children use inhalers incorrectly even after instruction. For two age groups of children with asthma, we determined the proportions who used the once‐daily ELLIPTA dry‐powder inhaler (DPI) correctly, and who fou